Back

Prevalence and cardiovascular implications of mitral valve prolapse in marfan syndrome: insights from a multicenter observational study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Topics in paediatric cardiology (1) Paediatric Cardiology ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Andrea Impellizzeri

Barts Health NHS Trust, London (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
Optimization of the optimal anticoagulation strategy during cardiopulmonary bypass for neonates with congenital heart disease: a single-center randomized controlled study
Doctor T. Gao (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
The added value of cardiac MRI in paediatric rheumatologic disorders
Doctor A. Kannan (Houston, US)
Abstract Slides Video
Presentation thumbnail
Left ventricular global longitudinal strain is predictive of outcomes in children with biliary atresia
Doctor T. Doan (Houston, US)
Abstract Slides
Presentation thumbnail
Sudden cardiac death vs. myocardial infarction: analyzing age and racial disparities in mortality trends using CDC WONDER
Doctor B. Elsiraj (Abu Dhabi, AE)
Abstract Slides Video
Presentation thumbnail
Anomalous aortic origin of a right coronary artery: Large cohort medium to long term outcomes in repaired and unrepaired patients
Doctor S. Molossi (Houston, US)
Abstract Slides Video

Access the full session

Session thumbnail
Topics in paediatric cardiology (1)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Systemic manifestations of connective tissue abnormalities in patients with Mitral Valve Prolapse assessed by Cardiac Magnetic Resonance
thumbnail
Congress Presentation
Evaluation of exercise capacity and cardiovascular parameters through cardiopulmonary exercise testing in patients with Marfan syndrome.
thumbnail
Congress Presentation
Mitral valve prolapse: arrhythmic risk and prognosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources